NSP
Insperity, Inc.38.88
+0.66+1.73%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
HRScale upgrades prioritized, plans derisk
Q&A drilled into HRScale momentum, revealing prioritization of larger HR360 upgrades to curb attrition and build a quarterly queue—beta live April, more in July/October—positioning 6,000-8,000 worksite employees by year-end mainly for 2027 lift. Client-sponsored health plans surfaced as a deliberate risk-reducer, ramped strategically amid elevated claims, complementing UHC tweaks for ~2% cost relief. Churn featured the widest profitability spread in years, with low-margin clients culled to boost recovery. Pricing averages teens across 60% renewals ahead, though netted lower post-negotiation. Retention hit 83% in 2025. Management fielded queries crisply. Watch HRScale traction and pricing stickiness.
Key Stats
Market Cap
1.47BP/E (TTM)
81.00Basic EPS (TTM)
0.48Dividend Yield
0.06%Recent Filings
10-K
FY2025 results
Insperity's FY2025 revenues climbed 4% to $6.8B on 1% WSEE growth to 310,089 average monthly paid and 3% higher pricing, yet gross profit plunged 14% to $900M as benefits costs surged 9% per participant amid elevated claims. Q4 ended strong with 312,377 average WSEEs, up 1% y/y, signaling steady momentum despite annual pressures. Operating expenses dipped 3% to $910M on lower professional services and travel, while $90M dividends and $19M buybacks underscored capital returns; working capital stood at $102M. Q4 margins held amid seasonal tax and claims peaks. Client retention hit 83%. Health reform risks loom over benefits plans.
8-K
Q4 loss, 4% cuts, 2026 rebound
Insperity reported Q4 2025 revenues up 3% to $1.7B with average WSEEs at 312,377, yet posted a $33M net loss from elevated benefits costs that slashed gross profit 21%. Announced Realignment Plan cutting 4% of non-sales positions, expecting $9M one-time charges mostly in Q1 2026. Reorg sharpens focus. Guides 2026 adjusted EBITDA to $170M-$230M.
10-Q
Q3 FY2025 results
Insperity posted Q3 revenues of $1.6B, up 4% y/y on 1% WSEE growth and 3% higher pricing per WSEE, yet gross profit sank 15% to $195M from elevated health insurance trends and workers' comp costs. Operating expenses dipped 4% to $220M, mainly lower Workday implementation fees, but yielded a $25M operating loss versus breakeven last year; net loss hit $20M, matching operating after minor interest offset. Cash fell to $422M with $369M debt drawn on its $650M facility (available $280M); YTD operating cash used $533M on payroll timing. Solid geographically, with West and Southwest each over 20% of revenue. Client contract cancellations pose ongoing risk.
8-K
UHC deal extended to 2028
Insperity subsidiary amended its UnitedHealthcare medical coverage deal on November 3, 2025, locking in added cost savings from 2026 and extending through 2028, while offering annual pooling options at $500,000, $750,000, or $1 million caps. This counters Q3's $20 million net loss from soaring benefits costs, despite 4% revenue growth to $1.6 billion on 1% higher WSEEs. Deal sharpens 2026 outlook.
IPO
Website
Employees
Sector
Industry